News

Belinostat is also under investigation in a randomized phase 2 trial, as a combination therapy with carboplatin and paclitaxel, for cancer of unknown primary (CUP). Additionally, the NCI

As per the terms of the co-marketing alliance the companies will jointly promote the use of a new synthetic-ligand affinity adsorbent, marketed under the trade-name AlbuPure, as a

Under the collaboration and license agreement, Abbott will lead the development and commercialization of monoclonal antibodies targeting the cMet receptor. Pierre Fabre will receive an initial $25m upfront

Under the terms of the agreement, Therapure will be responsible for the manufacture of two major plasma proteins and LFB will remain responsible for global regulatory approvals and

Lee International will advise and assist TNS in the research and development of products most suitable for this market. The market includes Mainland China, Cambodia, Vietnam, Hong Kong,

The newly issued patent (US 7,655,252) is licensed from the University of Michigan to NanoBio on an exclusive, worldwide basis. With the new patent, NanoBio now holds six

The company said that they have the final color and taste of the tablet, and managed to meet their end goal of having a tablet that dissolves in

XM02 is a granulocyte colony-stimulating factor (G-CSF) for reducing the duration of severe neutropenia and the incidence of febrile neutropenia, in patients treated with established myelosuppressive chemotherapy for

The acquisition expands Thermo Fisher’s portfolio of reagents and other consumables for the molecular biology research and diagnostics markets through the addition of its proprietary DNA polymerases, Phire